Histogen Inc. buy krebskrebs
Start price
19.10.20
/
50%
€38.00
Target price
04.11.21
€40.00
Performance (%)
-65.26%
End price
05.11.21
€13.20
Summary
This prediction ended on 05.11.21 with a price of €13.20. The BUY prediction by krebskrebs for Histogen Inc. performed very badly with a performance of -65.26%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Histogen Inc. | - | - | - | - |
| iShares Core DAX® | 1.662% | 4.835% | 17.361% | 19.329% |
| iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% | 55.157% |
| iShares Nikkei 225® | -2.139% | -4.786% | 13.099% | 7.393% |
| iShares S&P 500 | 0.564% | 0.775% | 29.181% | 46.527% |
Comments by krebskrebs for this prediction
In the thread Histogen Inc. diskutieren
In the thread Trading Histogen Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten